Determination of task group 43 dosimetric parameters for CSM40 137Cs source for use in brachytherapy

被引：2

作者：

Firoozabadi M.M. ^{[1
]}

Jimabadi E. ^{[1
]}

Ghorbani M. ^{[2
]}

Behmadi M. ^{[3
]}

机构：

[1] Department of Physics, Faculty of Sciences, University of Birjand, Birjand

[2] Biomedical Engineering and Medical Physics Department, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Velenjak, Tehran

[3] Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad

来源：

Radiological Physics and Technology | 2018年 / 11卷 / 1期

关键词：

Brachytherapy; CSM40 [!sup]137[!/sup]Cs source; Monte Carlo simulation; TG-43 dosimetric parameters;

D O I：

10.1007/s12194-017-0440-3

中图分类号：

学科分类号：

摘要：

The CSM40 137Cs source model is currently being used in clinical brachytherapy. According to the recommendations of task group No. 43 (TG-43) of the American Association of Physicists in Medicine, dosimetry parameters of brachytherapy sources should be determined by two independent investigators before their clinical use. The aim of this study was to determine the TG-43 dosimetry parameters for a medium-dose-rate CSM40 137Cs source. The determined dosimetric parameters included the air kerma strength, dose rate constant, radial dose function, and anisotropy function. To determine the source’s dosimetric parameters, the CSM40 source was stimulated by the Monte Carlo N-Particle MCNP code. The TG-43 parameters were compared with the data of Vijande et al. on this source. The results showed that the dosimetry parameters for this source had good agreement with the results of Vijande et al. The dosimetric parameters of the CSM40 source can be used in treatment-planning systems incorporating this source model. The data can also be used for the quality assurance of treatment-planning systems. © 2018, Japanese Society of Radiological Technology and Japan Society of Medical Physics.

引用

页码：82 / 90

页数：8

共 16 条

[1] Suntharalingam N., Podgorsak E.B., Tolli H., Brachytherapy: physical and clinical aspects, Radiation oncology physics: a handbook for teachers and students, pp. 451-484, (2005)
[2] Meigooni A.S., Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM radiation therapy committee task group No. 43, Med Phys, 22, pp. 209-234, (1995)
[3] Rivard M.J., Coursey B.M., DeWerd L.A., Et al., Update of AAPM task group No. 43 report: a revised AAPM protocol for brachytherapy dose calculations, Med Phys, 31, pp. 633-674, (2004)
[4] Vijande J., Granero D., Perez-Calatayud J., Et al., Monte Carlo dosimetric study of the medium dose rate CSM40 source, Appl Radiat Isot, 82, pp. 283-288, (2013)
[5] Zaker N., Zehtabian M., Sina S., Et al., Comparison of TG-43 dosimetric parameters of brachytherapy sources obtained by three different versions of MCNP codes, J Appl Clin Med Phys., 17, (2016)
[6] Bahreyni Toossi M.T., Ghorbani M., Rostami A., Et al., Comparison of the hypothetical 57Co brachytherapy source with the 192Ir source, Contemp Oncol, 20, pp. 327-334, (2016)
[7] Pakravan D., Ghorbani M., Meigooni A.S., Evaluation of 101Rh as a brachytherapy source, J Contemp Brachytherapy, 7, pp. 171-180, (2015)
[8] Reed J.L., Rivard M.J., Micka J.A., Et al., Experimental and Monte Carlo dosimetric characterization of a 1 cm 103Pd brachytherapy source, Brachytherapy, 13, pp. 657-667, (2014)
[9] Sheikholeslami S., Nedaie H.A., Sadeghi M., Et al., Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source, J Appl Clin Med Phys, 17, (2016)
[10] Baghani H.R., Lohrabian V., Aghamiri M.R., Et al., Monte Carlo determination of dosimetric parameters of a new 125I brachytherapy source according to AAPM TG-43 (U1) protocol, Arch Iran Med, 19, pp. 186-191, (2016)

← 1 2 →